chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chills; high temperature; red rash; Red rash; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (high temperature), VACCINATION SITE RASH (red rash) and VACCINATION SITE ERYTHEMA (Red rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PYREXIA (high temperature), VACCINATION SITE RASH (red rash) and VACCINATION SITE ERYTHEMA (Red rash). At the time of the report, CHILLS (chills), PYREXIA (high temperature), VACCINATION SITE RASH (red rash) and VACCINATION SITE ERYTHEMA (Red rash) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. No concomitant medications were provided. Treatment medications was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: The email address updated.
very high fever 105 or higher for 3 days;jerking, lethargic, could not stand up;
Pt states he had rash on side/back for about a week.  Rash was not raised, and not painful or itchy.
Swelling and erythema in the leg about 4" in size around the site of DTAP shot.
Patient called pharmacy stating that her face and eye on right side was swelling.  The pharmacist asked if her tongue or lips were swelling and she responded the throat on the right side felt tight.    The pharmacist recommended that  the patient should go to the ER for observation.  She recieved a covid vaccine about 3:17 and called the pharmacy about 5:10
This patient in less than 72 hours after vaccines, began vomiting, diarrhea, fever, irritability, restless sleep, fat heartbeat, tired. The pediatric doctor refused to examine the patient and refused to file a report.
Information has been received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. Concurrent conditions, medical history of the patients were not reported. On unknown dates from 09-FEB-2015 through 02-APR-2015, the patients were vaccinated with doses of GARDASIL (lot # K006124, expiry date: 02-FEB-2017), dose, route unspecified, which were improperly stored on 09-FEB-2015. No adverse effects reported. No product quality complaint (PQC) involved. The relatedness between the event and therapy with GARDASIL was not reported. This is one of several reports received from the same source. Additional information has been requested.
Itching began on 10/17, followed that evening by visible hives on my upper body. On 10/18, this continued so I called my doctor's office for advice and was told to take an antihistamine which I had in the house. On 10/19, the hives continued to spread. I again called the doctor's office, and they recommended I take 180mg Allegra twice daily and Benadryl 4-6 times daily. I started those that evening, at which time I was experiencing intense itching on my legs and groin area, and temperature as high as 100.9. When I went to bed, I noticed large dark red/purple blotches on my legs, which alarmed me. On 10/20, no improvement, so I again called the doctor's office, as I was also noticing that my face looked a little pink in spots. The doctor prescribed the steroid Medrol, which I began that evening, in addition to the antihistamines. On 10/21, they were able to get me into the office for an exam, and diagnosed Vasculitis on my legs, and changed the steroid from Medrol to Prednisone. They also took pictures and drew blood, for which I have not received results. From that point on, improvement came quickly. Today, 10/26 the legs blotches are 99% cleared up, and I feel fairly normal, with the exception of some tiredness and sinus congestion.
Pregnancy; Initial Report Received on 28-Jul-2021  A pregnant female, over the age of 18 years (state, race and ethnicity not provided), reported to the pregnancy registry that she received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. At the time of report, she reported being 6-weeks pregnant.    No relevant medical history was reported.  No concomitant medications were reported.  On 13-Jul-2021, the pregnant patient was vaccinated with a "booster" of HEPLISAV-B (Lot #, expiration date and NDC # not reported).    She declined participation the registry and no additional information was provided.  Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Patient reported painful blistering and pink discoloration to the skin on the left side of the face. The reported onset was 7 days after administration and resolved after 2 weeks. No treatment was reported.
8:20am we administered a Tdap in the right arm a minute later the patient fainted. The nurse observed that the kid started to make involuntary movements with the head and rolled the eyes like if it was a seizure. Then he was lethargic for 5 minutes and then he came back.
Breakthrough covid case; Pt presented to ER on 6/24/22 with c/o sinus drainage, cough, body aches. Hx of Pfizer vaccine x 3 doses. Pt recently traveled. DC home.
Diarrhea; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and PAIN (Soreness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and PAIN (Soreness). At the time of the report, DIARRHOEA (Diarrhea) and PAIN (Soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant produces were reported. No treatment information was provided.
feels cold; skin feels sensitive; described experiencing something that sounded like "super hydrated" and other symptom "twice"; temperature; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (feels cold), SENSITIVE SKIN (skin feels sensitive), VACCINATION COMPLICATION (described experiencing something that sounded like "super hydrated" and other symptom "twice") and PYREXIA (temperature) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 076C21A and 050E214) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING COLD (feels cold), SENSITIVE SKIN (skin feels sensitive), VACCINATION COMPLICATION (described experiencing something that sounded like "super hydrated" and other symptom "twice") and PYREXIA (temperature). At the time of the report, FEELING COLD (feels cold), SENSITIVE SKIN (skin feels sensitive), VACCINATION COMPLICATION (described experiencing something that sounded like "super hydrated" and other symptom "twice") and PYREXIA (temperature) outcome was unknown.            No concomitant medication was provided.  Patient reported  side effects from the second dose of the Moderna COVID-19 vaccine. He described experiencing something that sounded like super hydrated and other symptom twice ,  he just said that before he got the vaccines he felt great. He also said he had temperature, feels cold and his skin feels sensitive.  No treatment information was provided. Patient took the vaccine from Pharmacy.
I had nausea and disoriented, kind of confused. It went of for several days. I felt very sick for several days, that's when I called my doctor. I don't remember the details. I got COVID-19 a few days later, I couldn't breath, I went to the hospital. I stayed for 2-3 days, I was really sick at home.
FEBRILE SEIZURE 19 DAYS PAST MMR, VAR, ACTHIB, PCV7. NO RECURRENT SEIZURES AFTERWARD.
The booster didn't stop me from getting Omicron; Lack of efficacy; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (The booster didn't stop me from getting Omicron) and DRUG INEFFECTIVE (Lack of efficacy) in a female patient of an unknown age who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (The booster didn't stop me from getting Omicron) and DRUG INEFFECTIVE (Lack of efficacy). At the time of the report, COVID-19 (The booster didn't stop me from getting Omicron) and DRUG INEFFECTIVE (Lack of efficacy) outcome was unknown.        For mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. A survey respondent participated in a qualitative survey. In response to a survey question, respondent stated that the booster didn't stop patient from getting Omicron. It was unknown if the event caused the patient to seek medical care. No treatment drugs were reported. Company comment: This spontaneous case concerns a female patient with unspecified age, with no reported medical history, who experienced the unexpected non-serious adverse events of special interest, COVID-19 (that the booster didn't stop me from getting Omicron) that occurred in context to a dose of mRNA-1273.222 vaccination. Latency cannot be assessed since vaccination date was not disclosed. No additional information is available regarding medical history and concomitant medication received and treatment details. The event outcome was unknown. Ongoing Covid 19 pandemic could be considered as confounder to the event.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.; Sender's Comments: This spontaneous case concerns a female patient with unspecified age, with no reported medical history, who experienced the unexpected non-serious adverse events of special interest, COVID-19 (that the booster didn't stop me from getting Omicron) that occurred in context to a dose of mRNA-1273.222 vaccination. Latency cannot be assessed since vaccination date was not disclosed. No additional information is available regarding medical history and concomitant medication received and treatment details. The event outcome was unknown. Ongoing Covid 19 pandemic could be considered as confounder to the event.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.
Patient given FLULAVAL which is not indicated for patients <18 yrs. Patients without any side effects.
COVID 19 Treatment; COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Jul2022 at 16:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 45 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), as dose 2 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine janssen (COVID-19 VACCINE JANSSEN), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "32 bmi" (unspecified if ongoing). Concomitant medication(s) included: VYVANSE, start date: 01Dec2020, stop date: 25Aug2022. Past drug history included: Iodine, reaction(s): "Known allergies: Iodine". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment"; DISEASE RECURRENCE (medically significant) with onset 22Aug2022 at 15:00, outcome "not recovered", described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: Body mass index: 32; SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. It was unknown if therapeutic measures were taken as a result of disease recurrence. Clinical course: Paxlovid start date: 11Aug2022, stop date: 16Aug2022. The patient was fully vaccinated and double boosted. J&J, then Moderna booster then Pfizer booster. She took Paxlovid and 6 days later she became ill again with cough, runny nose, shortness of breath with difficulty breathing, fever and lethargy. She was on day 16 since first symptoms and felt like she was getting worse.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Headache that started about 30 minutes after her vaccine (which she got at 11:30am) and became strong around 4:30pm, causing her to have nausea and vomiting for about 1 hour with blurry vision. Her symptoms improved with 2 pills of regular strength advil. Her headache went away and she no longer has symptoms today.
Pt described hives of Right upper arm near injection site. Full body pruritis, and rash around mouth within 12 hours of vaccine. Other side effects included body aches, fatigue, and HA lasting up to two weeks
pt recvd vax; pt cried w/ shots; never stopped for more than 5min until about 11pm; fever to 102;
This medically confirmed spontaneous report (initial receipt: 26-Feb-2016) concerns a 61 year-old male patient. On 10-Sep-2015, the patient received AFLURIA (batch number U55406; expiry date: 30-Jun-2016 yet reported as 12-Jun-2016) 0.5 ml via the intramuscular route. The AFLURIA vaccine was stored at 0.6 to 1.1 degrees Celsius (reported as 33-34 degrees Fahrenheit) multiple times. The last excursion was 0 degrees Celsius (reported as 32 degrees Fahrenheit) for no more than 24 hours. The outcome was not reported.
My arm was swore and the same day i had cough. I had blisters and it became bump
Narrative:  51yo male Pt on 12/4/2021 presented to ER with extensive cardiac hx. 2 stents / stemi LAD 8/2012, CATH 5/10/17-stent thrombosis , hyperlipidemia, dm, htn. Substernal chest pain,dyspnea upon exertion. Pt was found to be having an acute MI and was transferred to  Hospital cath lab and found 100% blockage. Pt treated at this hospital. Hospital then notified Pt had died on 12/12/2021 at a different hospital (non-resident facility) health facility. Pt had received covid vaccines on 3/14/21 & 4/11/21. This death is  not related to covid vaccines.
vaccine received 9/7/07-pt developed sore dull pain 1/10 x 3-4 days-that improved but did not resolve completely. now continues with intermittent dull and pain. 2/10 with reaching behind himself and across his body in front. Has been almost 8 weeks.
Received 2nd dose of Moderna Covid-19 vaccine on Monday 1/25/21.  Patient experience fever, achiness, dizziness, fatigue, headache, low grade fever over the course of the next day.  Patient presented in the ED today 1/27/21 after a feeling of a rash, welts, and a feeling like burning.
Seen in office 10/1/12 vomiting & diarrhea illness within 48 hours of receiving FLUMIST vaccine.
no adverse event; Improperly stored administered vaccines; This spontaneous report was received from a registered nurse and from vaccine coordinator and refers to a patient of unknown age and gender. The patient's concurrent conditions, historical conditions and concomitant medications were not reported.   On 08-SEP-2021, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # T041687 expiration date 10-DEC-2022 (dose, route of administration and anatomical location were not reported) for prophylaxis (product storage error). The suspect vaccine was stored in a temperature from -10 degree Celsius (C) to 8 C for 5 hours and 10 minutes. There was previous temperature excursion - the vaccine was stored in a temperature from -10 C to 8 C for 8 hours and 41 minutes and for 3 hours and 35 minutes. No additional adverse events were reported (no adverse event).   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2110USA005066: US-009507513-2109USA006582: US-009507513-2109USA006583: US-009507513-2109USA006584: US-009507513-2109USA006585: US-009507513-2109USA006586: US-009507513-2109USA006587: US-009507513-2109USA006588: US-009507513-2109USA006589: US-009507513-2109USA006591: US-009507513-2109USA006592: US-009507513-2109USA006593: US-009507513-2109USA006594: US-009507513-2109USA006595: US-009507513-2109USA006596: US-009507513-2109USA006597: US-009507513-2109USA006537:
Approx 4-5 minutes after receiving Flu vaccine injection, patient told Grandma he "couldn't breathe" and he wanted her to "breathe on him". He spit his gum her hair and because more limp on her shoulder. She summoned help - office staff immediately in room. Patient pale, spit up small - moderate amount thick clear mucous with blue (gum was blue). Patient never lost consciousness, but was pale, RR ~24, HR 60's. Placed on left side on table, O2 4L administered per NC, O2 Sat monitor on finger (O2 Sat 100% HR 70). Both clinic doctor summoned at present. Evaluated patient, breath sounds clear and equal, HR regular. O2 administered ~10-15 minutes, Sat remained 100. HR 70-90's. After ~25 minutes, patient sat up (O2 Sat 98 in RA, HR 92). Took sips H2O and retained. Mom present as well as Grandma. Patient standing, taking few steps 96.8 after ~ 1 hour. Breath sounds remain clear, RR 32, HR 90. After approximately 1 hr, left office with mom and Grandma with instructions to continue observing patient and go to ER if untoward symptoms arise. Of note is that Grandma states that she "faints" with injections and that patient's 10 year old sibling "almost fainted" after injection a couple of weeks ago. Patient went into ER later the afternoon of 10/19/07. ER doctor evaluated patient and pronounces him OK, mom states. Today, 10/22/07, mom states patient is "totally well and returned to normal." Mom is aware that VAERS report is being filed.
Redness, swelling, circled at 16 cm (by Mom) per Mom's report.
approx 6pm I started having white "lighting" flashes in left eye. Started while I was walking my dog. No strenuous exercise. Then they came more frequently , white flashes. I patched my eye with gauze, and it improved just a little.  I Went to bed, woke up and only occasionally experienced white flashes, I then took 800mg Motrin, and a 10 mg Zyrtec. Then more came in the evening, I then took a decongestant and more antihistmine
Pt recvd 2nd dose of Engerix-B & exp migraine which resolved; Reporter indicated this past month MAR92 pt has had a kidney ailment; 3MAR92 titer result was 0;
w/in 1st hr threw up 3 times;slept straight through until 330 (5 hrs p/vax) immed started high pitched inconsolable screaming for 45 mins which ended w/suddenly going to sleep;3 days p/vax had episode of shivering;trembling;slep extensively
just contracted COVID as of Sunday December 5th, 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (just contracted COVID as of Sunday December 5th, 2021) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Dec-2021, the patient experienced COVID-19 (just contracted COVID as of Sunday December 5th, 2021). At the time of the report, COVID-19 (just contracted COVID as of Sunday December 5th, 2021) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Dec-2021, SARS-CoV-2 test: positive (Positive) contracted COVID as of Sunday December 5th, 2021.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. It was reported that patient wanted to know when the patient can take booster dose.  Company comment: This spontaneous case concerns a patient of an unknown age and gender, with no reported medical history, who experienced the non-serious, unexpected AESI event of Covid-19, 8 months after patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine). The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a patient of an unknown age and gender, with no reported medical history, who experienced the non-serious, unexpected AESI event of Covid-19, 8 months after patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine). The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.
Patient received his second dose of the Moderna vaccine on 5/21/21. On the morning of 5/22/21, patient started having issues with mobility, heavy sweats, body aches, and headache, although he had no fever and maintained his sense of smell and taste. Patient was later hospitalized and tested positive for COVID on Thursday, May 27, 2021. Patient passed away on Friday, May 28, 2021.
Exactly two weeks after my first vaccine I started vaginally bleeding extremely heavy and started to experience cramping similar to a menstrual cycle which I have not experienced in 10 years since I received my first Nexplanon implant.
sore arm; headache; fever (102.2); chills; nausea; This is a spontaneous report from a contactable consumer (patient).   A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL3247), dose 2 via an unspecified route of administration, administered in Left arm on 23Mar2021 10:15 (at the age of 50-years-old) as dose 2, single for covid-19 immunization. The patient had no medical history and concomitant medications. Patient historical vaccine included received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL3247), dose 2 via an unspecified route of administration, administered in Left arm on 02Mar2021 10:15 (at the age of 50-years-old) as dose 1, single for covid-19 immunization. Prior to vaccination, patient was not diagnosed with COVID-19, did not receive any other vaccines within 4 weeks and no other medications within 2 weeks. Since the vaccination, has the patient has not been tested for COVID-19. First symptoms of reaction began to present 5 hours after injection. Injection 10:15 AM ET, first symptoms were sore arm, mild headache at 3:15 PM. Additional symptoms appeared and became more intense in the next few hours, peaking about 9 hours later at12:00 AM. Full reaction included sore arm, headache, fever (102.2), chills, nausea. Tylenol was taken as treatment. The patient underwent lab tests and procedures which included body temperature: 102.2 (unspecified units). The outcome of the events was recovered.  No follow up attempts are possible. No further information is expected.